Related references
Note: Only part of the references are listed.Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
Stefan Hagel et al.
INTENSIVE CARE MEDICINE (2022)
β-lactam dosing at the early phase of sepsis: Performance of a pragmatic protocol for target concentration achievement in a prospective cohort study
Hadrien Winiszewski et al.
JOURNAL OF CRITICAL CARE (2022)
Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population-A prospective, multi-center, observational study (BLAST 1)
Nathalie Grace Chua et al.
JOURNAL OF CRITICAL CARE (2022)
Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools
Ferdinand Anton Weinelt et al.
ANTIBIOTICS-BASEL (2022)
Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis
Rekha Pai Mangalore et al.
CLINICAL INFECTIOUS DISEASES (2022)
Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the 'Maximum Tolerable Dose'
Sofie A. M. Dhaese et al.
ANTIBIOTICS-BASEL (2022)
Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis
Rekha Pai Mangalore et al.
CLINICAL INFECTIOUS DISEASES (2022)
Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections
Milo Gatti et al.
ANTIBIOTICS-BASEL (2021)
Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients
Joan Antoni Schoenenberger-Arnaiz et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2020)
Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples
Mohammad H. Al-Shaer et al.
THERAPEUTIC DRUG MONITORING (2020)
Population Pharmacokinetics of Piperacillin following Continuous Infusion in Critically Ill Patients and Impact of Renal Function on Target Attainment
Vibeke Klastrup et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2020)
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis
Sarah Fawaz et al.
BMC INFECTIOUS DISEASES (2020)
Therapeutic Drug Monitoring of Meropenem and Piperacillin in Critical Illness-Experience and Recommendations from One Year in Routine Clinical Practice
Christina Scharf et al.
ANTIBIOTICS-BASEL (2020)
What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review
Chandra Datta Sumi et al.
CLINICAL PHARMACOKINETICS (2019)
Measuring Unbound Versus Total Piperacillin Concentrations in Plasma of Critically Ill Patients: Methodological Issues and Relevance
Sofie Colman et al.
THERAPEUTIC DRUG MONITORING (2019)
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience
Daniel C. Richter et al.
INFECTION (2019)
MIC-based dose adjustment: facts and fables
Johan W. Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Augmented Renal Clearance in Critically Ill Patients: A Systematic Review
Idoia Bilbao-Meseguer et al.
CLINICAL PHARMACOKINETICS (2018)
A complete and multifaceted overview of antibiotic use and infection diagnosis in the intensive care unit: results from a prospective four-year registration
Liesbet De Bus et al.
CRITICAL CARE (2018)
Neurotoxic Concentration of Piperacillin during Continuous Infusion in Critically Ill Patients
Marie-Charlotte Quinton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Ultrafast quantification of β-lactam antibiotics in human plasma using UPLC-MS/MS
Mieke Carlier et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2015)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
COSARA: Integrated Service Platform for Infection Surveillance and Antibiotic Management in the ICU
Kristof Steurbaut et al.
JOURNAL OF MEDICAL SYSTEMS (2012)
Share Paper
